Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Postural Orthostatic Tachycardia Syndrome in Women

Panel Discussion on The Role of GLP-1 in the Management of CKD in T2D

Big Heads & Small Heads

Peanut Allergy

expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis